A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.

Preclinical Imaging Market is Segmented by Type (Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging ...

Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing ...

Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on ...

WVU has formed a strategic partnership with GATC Health Corp, a tech-bio company that uses artificial intelligence to ...

A collaborative research team from POSTECH has successfully developed a gastric cancer model using 3D bioprinting technology ...

Exo-Top was established under the jurisdiction of the State of Nevada. Basing Exo-Top in the U.S. offers key advantages, including proximity to strategic partners, access to a robust biopharma ...

A research team affiliated with UNIST has unveiled an innovative technology to eliminate drug-resistant cancer cells using ...

Fortunately, cutting-edge technologies such as AI, blockchain, and big data have the potential to eliminate costly inefficiencies in the drug discovery and development process. The high risk ...

ERLANGEN, GERMANY AND VILNIUS, LITHUANIA - Mallia Therapeutics, a German biopharmaceutical company, and Northway Biotech, a ...

The platform enables direct, unbiased genome-wide identification and quantification of the exact position of double strand DNA breaks in edited cells.